Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Valproic acid 500mg e/c tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valproic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproic acid 150 mg gastro-resistant oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely valproic acid 300 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely valproic acid 500 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valproic acid 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium valproate |
Is a |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valproic acid measurement |
Component |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate blood measurement |
Component |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Serum sodium valproate measurement (procedure) |
Component |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valproate |
Is a |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valproic acid 250mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Measurement of free valproic acid (procedure) |
Component |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproic acid 125 mg gastro-resistant oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely valproic acid 250 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valproic acid 500mg delayed release capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing valproic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing valproic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproic acid 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproic acid 250 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproate sodium 100mg/mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Divalproex sodium |
Is modification of (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium valproate |
Is modification of (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valpromide |
Is modification of (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely valproic acid 500 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valproic acid 500 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproic acid 150 mg gastro-resistant oral capsule |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproic acid 150 mg gastro-resistant oral capsule |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valproic acid 300 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valproic acid 300 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproic acid 500mg e/c tablet (substance) |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproic acid 250 mg oral capsule |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to valproic acid (finding) |
Causative agent (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only valproic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only valproic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproic acid only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproic acid 125 mg gastro-resistant oral capsule |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproic acid 125 mg gastro-resistant oral capsule |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valproic acid 250 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valproic acid 250 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valproic acid 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valproic acid 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproic acid (as valproate semisodium) 125 mg gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valproic acid 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely valproic acid 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproic acid 50 mg/mL oral solution |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Valproic acid 50 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Congenital malformation caused by valproic acid |
Causative agent (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 133 milligram and valproic acid 58 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 133 milligram and valproic acid 58 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 200 milligram and valproic acid 87 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium valproate 200 milligram and valproic acid 87 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 66.66 mg and valproic acid 29.03 mg prolonged-release oral granules sachet |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 66.66 mg and valproic acid 29.03 mg prolonged-release oral granules sachet |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 166.76 mg and valproic acid 72.61 mg prolonged-release oral granules sachet |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 166.76 mg and valproic acid 72.61 mg prolonged-release oral granules sachet |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
Has precise active ingredient |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
Has basis of strength substance (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adverse reaction caused by valproic acid (disorder) |
Causative agent (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Poisoning caused by valproic acid (disorder) |
Causative agent (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |